Internal Medicine, Cardiovascular Disease · Melbourne, FL
NPI
1306899026
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1223 Gateway Dr
Melbourne, FL, 32901
Phone (321) 312-3487
Groups this clinician bills Medicare through
Medicare paid, 2024
$580K
26,771 services
Medicare patients, 2024
1,676
Average age 76
Drug cost, 2024
$3.9M
12,922 prescriptions
Company payments, 2025
$231
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Enrique D Polanco was code J1306 (injection, inclisiran, 1 mg), 17,608 times for 39 patients. In total Enrique D Polanco billed 26,771 services in 82 codes, and Medicare paid $580K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 17,608 | 39 | $9.50 | $167K |
| 93000 Electrocardiogram | Office | 1,312 | 915 | $10.09 | $13K |
| J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 1,026 | 19 | $0.46 | $471 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 947 | 585 | $12.56 | $12K |
| 99214 Office E&M - Established | Office | 934 | 572 | $90.32 | $84K |
| 99213 Office E&M - Established | Office | 336 | 287 | $64.28 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 325 | 170 | $91.32 | $30K |
| 93306 Echocardiography (TTE/TEE) | Facility | 279 | 273 | $52.36 | $15K |
| 93306 Echocardiography (TTE/TEE) | Office | 269 | 263 | $136.37 | $37K |
| 99223 Hospital E&M - Initial | Facility | 210 | 195 | $132.47 | $28K |
| 93296 External Electrocardiographic Monitoring | Office | 204 | 97 | $14.75 | $3,010 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 185 | 47 | $3.43 | $635 |
| 99232 Hospital E&M - Subsequent | Facility | 169 | 119 | $60.34 | $10K |
| 93294 External Electrocardiographic Monitoring | Office | 156 | 72 | $20.20 | $3,152 |
| 93010 Electrocardiogram | Facility | 142 | 110 | $6.17 | $876 |
By year: 2022 $450K for 14,673 services; 2023 $530K for 27,904 services; 2024 $580K for 26,771 services.
Medicare prescription drug claims, 2024
In 2024, the drug Enrique D Polanco prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,033 prescriptions and refills. In total Enrique D Polanco wrote 12,922 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,033 | 2,879 | 330 | $16K |
| Metoprolol Succinate Generic | 997 | 2,682 | 310 | $22K |
| Rosuvastatin Calcium Generic | 759 | 2,112 | 257 | $14K |
| Eliquis Apixaban | 709 | 1,452 | 195 | $801K |
| Amlodipine Besylate Generic | 544 | 1,486 | 178 | $4,752 |
| Jardiance Empagliflozin | 529 | 1,131 | 148 | $569K |
| Clopidogrel Clopidogrel Bisulfate | 400 | 1,129 | 143 | $7,354 |
| Carvedilol Generic | 368 | 1,033 | 117 | $4,566 |
| Spironolactone Generic | 363 | 949 | 119 | $4,303 |
| Entresto Sacubitril/Valsartan | 350 | 678 | 93 | $433K |
| Furosemide Generic | 320 | 799 | 102 | $1,478 |
| Potassium Chloride Generic | 293 | 706 | 84 | $4,379 |
| Losartan Potassium Generic | 276 | 726 | 93 | $4,247 |
| Olmesartan Medoxomil Generic | 264 | 683 | 94 | $6,022 |
| Lisinopril Generic | 213 | 561 | 67 | $1,552 |
Brand drugs: - claims; generic drugs: 9,715 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Enrique D Polanco $231 ($231 in general payments such as food, travel and fees) from 4 companies. The largest payer was CVRx, Inc. with $105.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.